DTCFF
Price
$0.56
Change
+$0.01 (+1.82%)
Updated
Jun 13 closing price
Capitalization
27.93M
UNCY
Price
$4.86
Change
-$1.94 (-28.53%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
86.82M
49 days until earnings call
Interact to see
Advertisement

DTCFF vs UNCY

Header iconDTCFF vs UNCY Comparison
Open Charts DTCFF vs UNCYBanner chart's image
DEFENCE THERAPEUTICS
Price$0.56
Change+$0.01 (+1.82%)
Volume$2K
Capitalization27.93M
Unicycive Therapeutics
Price$4.86
Change-$1.94 (-28.53%)
Volume$13.82K
Capitalization86.82M
DTCFF vs UNCY Comparison Chart in %
Loading...
DTCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTCFF vs. UNCY commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCFF is a Hold and UNCY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (DTCFF: $0.56 vs. UNCY: $6.80)
Brand notoriety: DTCFF and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTCFF: 139% vs. UNCY: 358%
Market capitalization -- DTCFF: $27.93M vs. UNCY: $61.99M
DTCFF [@Biotechnology] is valued at $27.93M. UNCY’s [@Biotechnology] market capitalization is $61.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTCFF’s FA Score shows that 0 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • DTCFF’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, UNCY is a better buy in the long-term than DTCFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTCFF’s TA Score shows that 4 TA indicator(s) are bullish while UNCY’s TA Score has 5 bullish TA indicator(s).

  • DTCFF’s TA Score: 4 bullish, 1 bearish.
  • UNCY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DTCFF is a better buy in the short-term than UNCY.

Price Growth

DTCFF (@Biotechnology) experienced а 0.00% price change this week, while UNCY (@Biotechnology) price change was +918.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

UNCY is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UNCY($86.8M) has a higher market cap than DTCFF($27.9M). DTCFF YTD gains are higher at: 43.527 vs. UNCY (-14.379). UNCY has more cash in the bank: 26.1M vs. DTCFF (2.08M). UNCY has less debt than DTCFF: UNCY (694K) vs DTCFF (1.39M).
DTCFFUNCYDTCFF / UNCY
Capitalization27.9M86.8M32%
EBITDA-3.16MN/A-
Gain YTD43.527-14.379-303%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash2.08M26.1M8%
Total Debt1.39M694K201%
TECHNICAL ANALYSIS
Technical Analysis
DTCFFUNCY
RSI
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
52%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
62%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DTCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLRT0.02N/A
+13.21%
Metalert Inc
HTCTF0.12N/A
N/A
Hutchison Telecommunications Hong Kong Holdings Ltd.
MTPOF1.37N/A
N/A
Metropolitan Bank & Trust
ATEYY74.14-1.25
-1.65%
Advantest Corp.
NSRPF0.08N/A
-2.31%
Novo Resources Corp

DTCFF and

Correlation & Price change

A.I.dvisor tells us that DTCFF and BRCTF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DTCFF and BRCTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTCFF
1D Price
Change %
DTCFF100%
N/A
BRCTF - DTCFF
25%
Poorly correlated
N/A
CNSP - DTCFF
25%
Poorly correlated
+5.02%
NEVPF - DTCFF
22%
Poorly correlated
N/A
CABA - DTCFF
21%
Poorly correlated
-6.52%
UNCY - DTCFF
20%
Poorly correlated
+14.48%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with INDP. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+14.48%
INDP - UNCY
53%
Loosely correlated
+3063.04%
CDTX - UNCY
52%
Loosely correlated
+2.96%
ICU - UNCY
45%
Loosely correlated
-3.52%
CERO - UNCY
37%
Loosely correlated
-14.66%
IRD - UNCY
33%
Poorly correlated
-4.25%
More